Efficacy of the GemOx‐R regimen leads to the identification of Oxaliplatin as a highly effective drug against Mantle Cell Lymphoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2141|174|6|899-910

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.174, Iss.6, 2016-09, pp. : 899-910

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab, Gemcitabine, Cisplatin and Methylprednisolone (R‐GEM‐P) is an effective regimen in relapsed diffuse large B‐cell lymphoma

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 3, 2015-03 ,pp. : 219-226

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ibrutinib Is Effective in the Treatment of Autoimmune Haemolytic Anaemia in Mantle Cell Lymphoma

By  

Case Reports in Oncology, Vol. 10, Iss. 1, 2017-01 ,pp. : 127-129

Karger

Access to resources Recommend Favorite

Carfilzomib Inhibits Constitutive NF-κB Activation in Mantle Cell Lymphoma B Cells and Leads to the Induction of Apoptosis

By  

Acta Haematologica, Vol. 137, Iss. 2, 2017-02 ,pp. : 106-112

Karger

Access to resources Recommend Favorite

Intermediate doses of cytarabine plus granulocyte–colony‐stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with prior mobilization failure

By  

TRANSFUSION, Vol. 55, Iss. 4, 2015-04 ,pp. : 875-879

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pilot Trial of Systemic Methotrexate plus R-CHOP Regimen with Intrathecal Methotrexate for Simultaneous Central Nervous System and Systemic Diffuse Large B Cell Lymphoma

By  

Acta Haematologica, Vol. 133, Iss. 2, 2014-10 ,pp. : 179-182

Karger

Access to resources Recommend Favorite